Gorchakova O - Search Results

1

PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction.

Gorchakova O, Koch W, Mehilli J, von Beckerath N, Schwaiger M, Schömig A, Kastrati A. Gorchakova O, et al. Thromb Haemost. 2004 Jan;91(1):141-5. doi: 10.1160/TH03-06-0341. Thromb Haemost. 2004. PMID: 14691579 Clinical Trial.

2

G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease.

von Beckerath N, Schusterschitz Y, Koch W, Griesser K, Mehilli J, Gorchakova O, Schömig A, Kastrati A. von Beckerath N, et al. Among authors: gorchakova o. Atherosclerosis. 2003 Mar;167(1):135-9. doi: 10.1016/s0021-9150(02)00422-7. Atherosclerosis. 2003. PMID: 12618278

3

ABO locus O1 allele and risk of myocardial infarction.

von Beckerath N, Koch W, Mehilli J, Gorchakova O, Braun S, Schömig A, Kastrati A. von Beckerath N, et al. Among authors: gorchakova o. Blood Coagul Fibrinolysis. 2004 Jan;15(1):61-7. doi: 10.1097/00001721-200401000-00010. Blood Coagul Fibrinolysis. 2004. PMID: 15166945

4

Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.

Gorchakova O, Koch W, von Beckerath N, Mehilli J, Schömig A, Kastrati A. Gorchakova O, et al. Eur Heart J. 2003 May;24(9):820-7. doi: 10.1016/s0195-668x(02)00824-2. Eur Heart J. 2003. PMID: 12727149

5

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.

Kastrati A, von Beckerath N, Joost A, Pogatsa-Murray G, Gorchakova O, Schömig A. Kastrati A, et al. Among authors: gorchakova o. Circulation. 2004 Oct 5;110(14):1916-9. doi: 10.1161/01.CIR.0000137972.74120.12. Epub 2004 Jul 19. Circulation. 2004. PMID: 15262828 Clinical Trial.

6

Pharmacokinetics of clopidogrel after administration of a high loading dose.

Taubert D, Kastrati A, Harlfinger S, Gorchakova O, Lazar A, von Beckerath N, Schömig A, Schömig E. Taubert D, et al. Among authors: gorchakova o. Thromb Haemost. 2004 Aug;92(2):311-6. doi: 10.1160/TH04-02-0105. Thromb Haemost. 2004. PMID: 15269827

7

Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting.

Gorchakova O, von Beckerath N, Gawaz M, Mocz A, Joost A, Schömig A, Kastrati A. Gorchakova O, et al. Eur Heart J. 2004 Nov;25(21):1898-902. doi: 10.1016/j.ehj.2003.10.039. Eur Heart J. 2004. PMID: 15522468

8

Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.

Braun S, Ndrepepa G, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, Schömig A, Kastrati A. Braun S, et al. Among authors: gorchakova o. Am Heart J. 2005 Sep;150(3):550-6. doi: 10.1016/j.ahj.2004.10.008. Am Heart J. 2005. PMID: 16169339

9

Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.

Ndrepepa G, Braun S, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, Schömig A, Kastrati A. Ndrepepa G, et al. Among authors: gorchakova o. Clin Chim Acta. 2005 Oct;360(1-2):178-86. doi: 10.1016/j.cccn.2005.04.032. Clin Chim Acta. 2005. PMID: 15993392

10

[Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C].

Nozhkin MS, Lioznov DA, Antonova TV, Gorchakova OV, Goldstein EM, Popova MO, Shneyder TV. Nozhkin MS, et al. Among authors: gorchakova ov. Ter Arkh. 2023 Dec 22;95(11):919-923. doi: 10.26442/00403660.2023.11.202473. Ter Arkh. 2023. PMID: 38158946 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters